{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:04:40Z","timestamp":1786993480209,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2024R171"],"award-info":[{"award-number":["RSP2024R171"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jsps.2024.102104","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:34:15Z","timestamp":1715859255000},"page":"102104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies"],"prefix":"10.1007","volume":"32","author":[{"given":"Basmah N.","family":"Aldosari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-5453","authenticated-orcid":false,"given":"Mohamed Abbas","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal El Sayeh F.","family":"Abou El Ela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2024.102104_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12247-018-9335-z","article-title":"Hydrogel containing PEG-coated Fluconazole nanoparticles with enhanced solubility and antifungal activity","volume":"14","author":"Abdellatif","year":"2019","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jsps.2024.102104_b0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jsps.2021.04.018","article-title":"Fluconazole nanoparticles prepared by antisolvent precipitation technique: Physicochemical, in vitro, ex vivo and in vivo ocular evaluation","volume":"29","author":"Abou El Ela","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jsps.2024.102104_b0015","doi-asserted-by":"crossref","first-page":"e0200218","DOI":"10.1371\/journal.pone.0200218","article-title":"Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign","volume":"13","author":"Alshora","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jsps.2024.102104_b0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/10837450.2020.1744163","article-title":"Co-stabilization of pioglitazone HCL nanoparticles prepared by planetary ball milling: in-vitro and in-vivo evaluation","volume":"25","author":"Alshora","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jsps.2024.102104_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/03639040802282896","article-title":"Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders","volume":"35","author":"Chen","year":"2009","journal-title":"Drug Dev Ind. Pharm."},{"key":"10.1016\/j.jsps.2024.102104_b0030","first-page":"557","article-title":"Novel drug delivery technologies for insoluble drugs","volume":"42","author":"Chowdhary","year":"2005","journal-title":"Ind. Drugs."},{"key":"10.1016\/j.jsps.2024.102104_b0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhazmat.2010.09.060","article-title":"Rheological characterization of xanthan suspensions of nanoscale iron for injection in porous media","volume":"185","author":"Comba","year":"2011","journal-title":"J. Hazardous Materials."},{"key":"10.1016\/j.jsps.2024.102104_b0040","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1016\/j.watres.2009.05.046","article-title":"Stabilization of highly concentrated suspensions of iron nanoparticles using shear-thinning gels of xanthan gum","volume":"43","author":"Comba","year":"2009","journal-title":"Water Res."},{"key":"10.1016\/j.jsps.2024.102104_b0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2024.102104_b0050","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1081\/AL-100106841","article-title":"Quantitative determination of fluconazole in capsules and IV solutions by UV spectrophotometric methods","volume":"34","author":"G\u00f6\u011fer","year":"2001","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jsps.2024.102104_b0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1208\/s12249-010-9388-x","article-title":"Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy","volume":"11","author":"Gupta","year":"2010","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.jsps.2024.102104_b0060","first-page":"176","article-title":"Formulation and evaluation of fluconazole topical gel","volume":"4","author":"Helal","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jsps.2024.102104_b0065","first-page":"647","article-title":"Tenoxicam - Kollicoat IR\u00ae Binary Systems: physicochemical and biological evaluation","volume":"71","author":"Ibrahim","year":"2014","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.jsps.2024.102104_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsps.2018.07.018","article-title":"Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity","volume":"27","author":"Ibrahim","year":"2019","journal-title":"Saudi. Pharm. J."},{"key":"10.1016\/j.jsps.2024.102104_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","article-title":"Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers","volume":"19","author":"Kabanov","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jsps.2024.102104_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/15569521003801454","article-title":"Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis","volume":"29","author":"Mahdy","year":"2010","journal-title":"Cutaneous and Ocular Toxicology."},{"key":"10.1016\/j.jsps.2024.102104_b0085","series-title":"Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical emulsion sand suspensions","author":"Muller","year":"2000"},{"key":"10.1016\/j.jsps.2024.102104_b0090","series-title":"Pharmaceutical suspensions: from formulation development to manufacturing","first-page":"52","article-title":"General principles of suspensions","author":"Nutan","year":"2010"},{"key":"10.1016\/j.jsps.2024.102104_b0095","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2012.707203","article-title":"Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: Ex-vivo transcorneal permeation, corneal toxicity and irritation testing","volume":"39","author":"Pathak","year":"2013","journal-title":"Drug Development and Industrial Pharmacy."},{"key":"10.1016\/j.jsps.2024.102104_b0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","article-title":"Nanosuspensions: a promising drug delivery strategy","volume":"56","author":"Patravale","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jsps.2024.102104_b0105","first-page":"809","article-title":"Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique","volume":"13","author":"Ramezani","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.jsps.2024.102104_b0110","article-title":"Drug solubility: importance and enhancement techniques","volume":"1\u201311","author":"Savjani","year":"2012","journal-title":"ISRN Pharmaceutics."},{"key":"10.1016\/j.jsps.2024.102104_b0115","first-page":"1427","article-title":"Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system. Drug Design","volume":"9","author":"Sayed","year":"2015","journal-title":"Develop. Therapy."},{"key":"10.1016\/j.jsps.2024.102104_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2006.06.003","article-title":"Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs","volume":"64","author":"Sezgin","year":"2006","journal-title":"Eur. J. Pharm Biopharm"},{"key":"10.1016\/j.jsps.2024.102104_b0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1248\/cpb.44.372","article-title":"Solid dispersions of benidipine hydrochloride. II. Investigation of the interactions among drug, polymer and solvent in preparations","volume":"44","author":"Suzuki","year":"1996","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsps.2024.102104_b0130","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.2174\/138161209788923886","article-title":"Nanocarriers in ocular drug delivery: an update review","volume":"15","author":"Wadhwa","year":"2009","journal-title":"Current Pharm. Design."},{"key":"10.1016\/j.jsps.2024.102104_b0135","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jsps.2024.102104_b0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11051-012-1239-0","article-title":"Viscoelastic gels of guar and xanthan gum mixtures provide long-term stabilization of iron micro-and nanoparticles","volume":"14","author":"Xue","year":"2012","journal-title":"J. Nanopart. Res."},{"issue":"454","key":"10.1016\/j.jsps.2024.102104_b0145","first-page":"e451","article-title":"Severe fungal keratitis treated with subconjunctival fluconazole","volume":"140","author":"Yilmaz","year":"2005","journal-title":"Amer. J. Ophthalmol."},{"key":"10.1016\/j.jsps.2024.102104_b0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","article-title":"Microspheres and nanoparticles used in ocular delivery systems","volume":"16","author":"Zimmer","year":"1995","journal-title":"Advan. Drug Deliv. Reviews"},{"key":"10.1016\/j.jsps.2024.102104_b0155","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.3390\/ijms13078869","article-title":"Micronization of taxifolin by supercritical antisolvent process and evaluation of radical scavenging activity","volume":"13","author":"Zu","year":"2012","journal-title":"Int. J. Mol. Sci."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016424001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016424001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:25:27Z","timestamp":1736166327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016424001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1319016424001543"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102104","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"102104"}}